- Home
- Media Center
- Press releases
- Innovative Medicine
Innovative Medicine
DACOGEN® Approved In the European Union for the Treatment of Acute Myeloid Leukaemia
New treatment offers clinically significant benefit for patients
Janssen Connected Health Challenge Europe 2012 Launching To Spur Healthcare Innovation
Janssen Connected Health Challenge seeks transformational care ideas and offers awards totalling €30,000 to develop winning solutions
FDA Approves Expansion of Dosing Window to Help Avoid Missed Doses in INVEGA® SUSTENNA® Updated Product Label
Additional Prescribing Information Revisions Also Reflected in Updated Product Label
Johnson & Johnson Symposium Honors 2012 Recipients of the Dr. Paul Janssen Award for Biomedical Research
Dr. Victor Ambros and Dr. Gary Ruvkun Honored for Discovery of microRNAs;Symposium Celebrates the Power of Science to Change the World
Janssen Research & Development Submits Complete Response to the U.S. FDA on XARELTO® (rivaroxaban) for the Reduction of Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome
Supplemental New Drug Application for XARELTO® to reduce the risk of stent thrombosis in patients with acute coronary syndrome also resubmitted
Janssen Biotech Announces Global License and Development Agreement for Investigational Anti-Cancer Agent Daratumumab
Compound in Development for Multiple Myeloma